MD2323G2 - Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma - Google Patents

Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma

Info

Publication number
MD2323G2
MD2323G2 MDA20030151A MD20030151A MD2323G2 MD 2323 G2 MD2323 G2 MD 2323G2 MD A20030151 A MDA20030151 A MD A20030151A MD 20030151 A MD20030151 A MD 20030151A MD 2323 G2 MD2323 G2 MD 2323G2
Authority
MD
Moldova
Prior art keywords
uterine
preparation
isoturon
uterotonic
treatment
Prior art date
Application number
MDA20030151A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD2323F1 (en
Inventor
Валентин ФРИПТУ
Виктор ГИКАВЫЙ
Думитру СОФРОНИ
Еуджен ДЮГ
Корина КАРДАНЮК
Михаил ТОДИРАШ
Лилиан ГУЦУ
Екатерина СТРАТУ
Людмила НАКУ
Овидиу БАЛЦАТУ
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MDA20030151A priority Critical patent/MD2323G2/en
Publication of MD2323F1 publication Critical patent/MD2323F1/en
Publication of MD2323G2 publication Critical patent/MD2323G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to medicine, in particular to gynecology.Summary of the invention consists in using the S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma.The result of the invention consists in that for local use of said medicinal preparation in about 87% of cases it is attained a complete hemostasis in a reduced term and without side effects.
MDA20030151A 2003-06-23 2003-06-23 Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma MD2323G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20030151A MD2323G2 (en) 2003-06-23 2003-06-23 Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20030151A MD2323G2 (en) 2003-06-23 2003-06-23 Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma

Publications (2)

Publication Number Publication Date
MD2323F1 MD2323F1 (en) 2003-12-31
MD2323G2 true MD2323G2 (en) 2004-06-30

Family

ID=32026191

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20030151A MD2323G2 (en) 2003-06-23 2003-06-23 Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma

Country Status (1)

Country Link
MD (1) MD2323G2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2491G2 (en) * 2004-02-10 2005-01-31 Виктор ГИКАВЫЙ Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment
MD3592G2 (en) * 2007-11-06 2008-12-31 Рафаэль Баркан Uterotonic preparation for treating uterine hemorrhages in case of hysteromyoma
MD3645G2 (en) * 2008-01-10 2009-02-28 Валентин ФРИПТУ Method of treating uterine hypotonic postpartum hemorrhages
MD668Z (en) * 2013-02-22 2014-03-31 Георге АНГЕЛИЧ Method for conservative hemostasis of gastroduodenal hemorrhages

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2850G2 (en) * 2005-02-18 2006-07-31 Валентин ФРИПТУ Method of inducing the medicamental abortion

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD263C2 (en) * 1995-03-01 1995-12-31 Виктор ГИКАВЫЙ "Isoturon" means with antihypotensive activity
MD1431G2 (en) * 1998-01-16 2001-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Antihypotensive remedies

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD263C2 (en) * 1995-03-01 1995-12-31 Виктор ГИКАВЫЙ "Isoturon" means with antihypotensive activity
MD1431G2 (en) * 1998-01-16 2001-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Antihypotensive remedies

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Surcel V.I. Fibromiomul uterin. Editura Dacia, Cluj, 1998 *
Добротина А.Ф. Диагностика и лечение дисфункциональных маточных кровотечений. Медицина, 1978 *
Зайцев Н.А. Дисфункциональные маточные кровотечения. Здоровь'я, Киев, 1972 *
П. Дисфункциональные маточные кровотечения. Медицина и физкультура, 1971. *
Чапов П. Дисфункциональные маточные кровотечения. Медицина и физкультура, 1971 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2491G2 (en) * 2004-02-10 2005-01-31 Виктор ГИКАВЫЙ Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment
MD3592G2 (en) * 2007-11-06 2008-12-31 Рафаэль Баркан Uterotonic preparation for treating uterine hemorrhages in case of hysteromyoma
MD3645G2 (en) * 2008-01-10 2009-02-28 Валентин ФРИПТУ Method of treating uterine hypotonic postpartum hemorrhages
MD668Z (en) * 2013-02-22 2014-03-31 Георге АНГЕЛИЧ Method for conservative hemostasis of gastroduodenal hemorrhages

Also Published As

Publication number Publication date
MD2323F1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
MXPA04004842A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
PL370111A1 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
IL154888A (en) Non-aqueous pharmaceutical gel composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid and its use in the manufacture of a medicament for treatment of psoriasis
SE0001899D0 (en) New compounds
MX9605940A (en) Bio-aromatic compounds carrying an adamantyl group in ortho, pharmaceutical and cosmetic compositions containing them and utilization.
MXPA05011208A (en) Topical formulation of ivermectin for the treatment of dermatological conditions.
MXPA03005340A (en) Novel medicament compositions based on anticholinesterase drugs and on ciclesonides.
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
GB2431346B (en) A combination composition comprising paracetamol and ibuprofen
IL158668A0 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
HK1068606A1 (en) Novel aminobenzoephenones
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
WO2001076601A3 (en) Pharmaceutical compositions comprising salmeterol and ipratropium
MD2323G2 (en) Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma
HK1087010A1 (en) Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
PT1220676E (en) PREVENTION OF COLORCECTAL CANCER
WO2003007876A3 (en) N-fatty acid-amino acid conjugates and therapeutic uses
MXPA02008870A (en) Novel lhrh antagonists, production and use thereof as medicament.
WO2005002617A3 (en) Use of compositions comprising a soluble form of hla-g in the treatment of blood diseases
IL174134A0 (en) Use of a protein in the preparation of a medicament for treatment of fibrotic diseases
BR0313305A (en) Analgesic agent for newborn or fetal individuals
GB0128071D0 (en) Medicament
MD2491F1 (en) Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees